Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Macquarie Group Limited ( (AU:MQG) ) has shared an update.
Macquarie Group Limited has announced that it has ceased to be a substantial holder in Australian Clinical Labs Limited. This change in holding reflects a shift in Macquarie’s investment strategy and may impact its influence on the company’s voting securities. The announcement signifies a potential realignment of Macquarie’s portfolio, which could have implications for its market positioning and stakeholder interests.
The most recent analyst rating on (AU:MQG) stock is a Hold with a A$191.00 price target. To see the full list of analyst forecasts on Macquarie Group Limited stock, see the AU:MQG Stock Forecast page.
More about Macquarie Group Limited
Macquarie Group Limited is a global financial services group providing a diverse range of services including asset management, banking, advisory, and risk and capital solutions across debt, equity, and commodities markets. The company operates in various sectors worldwide, focusing on delivering innovative solutions to clients and stakeholders.
Average Trading Volume: 756,116
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$79.04B
See more insights into MQG stock on TipRanks’ Stock Analysis page.